Autoinflammatory Primary Immunodeficiency (PID) Gene Panel
Autoinflammatory diseases are systemic inflammatory disorders primarily caused by genetic mutations affecting innate immunity. These conditions result from inherited or de novo genetic alterations, leading to dysregulation of key immune components, including cytokines, chemokines, inflammatory signaling pathways, and immune effector cells. Testing for genetic mutations can facilitate accurate diagnosis and appropriate clinical management of autoinflammatory primary immunodeficiencies (PIDs).
Common Autoinflammatory Disorders:
Pityriasis rubra pilaris: Chronic skin inflammation with extensive scaling, caused by mutations in the CARD14 gene, inherited in an autosomal dominant pattern. Pustular psoriasis: Characterized by pustular skin lesions, scaling, and erythema due to mutations in the IL36RN gene.
Familial Mediterranean fever (FMF): Recurrent febrile episodes with chest pain, arthralgia, and abdominal pain, associated with mutations in the MEFV gene.
Tumor necrosis factor receptor-associated periodic syndrome (TRAPS): Resembles FMF but includes ocular and mucosal inflammation, with potential amyloidosis, due to TNFRSF1A gene mutations.
Chronic atypical neutrophilic dermatosis with lipodystrophy (CANDLE): Presents with persistent fever, annular plaques, periorbital edema, anemia, arthralgia, and progressive lipodystrophy.
Other rare conditions, very early-onset inflammatory bowel disease (IL10RA gene), Interleukin-1 receptor antagonist deficiency (IL1RN gene), Majeed syndrome (LPIN2 gene), Familial cold autoinflammatory syndromes (NLRP3, NLRP12 genes), Blau syndrome (NOD2 gene).
This panel (depends on the lab and lab use) employs targeted next-generation sequencing (NGS) to assess common pathogenic variants in the following genes: ADAM17, CARD14, DNASE1L3, IL10RA, IL10RB, IL1RN, IL28B, IL36RN, ISG15, LPIN2, MEFV, MVK, NLRP12, NLRP3 (CIAS1), NOD2 (CARD15), OTULIN, PLCG2, PSMB8, PSTPIP1 (CD2BP1), RBCK1 (HOIL1), SH3BP2, and TNFRSF1A. Additional confirmatory testing via Sanger sequencing may be conducted for select variants.
- Aids in diagnosing primary immunodeficiencies and autoinflammatory diseases
- Treatment selection and disease management
- Useful in screening family members with a familial history of autoinflammatory disorders
Negative for mutations analyzed (No mutation or pathogenic variant detected)
Whole blood, EDTA.
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: unstable
Acceptable specimens: cultured fibroblasts, skin biopsy, and extracted DNA.
- J Autoimmun. 2019 May;99:52-72. [PMID: 30795880]
- Immunol Lett. 2014 Oct;161(2):226-30. [PMID: 24452074]
- J Clin Immunol. 2016 May;36 Suppl 1:57-67. [PMID: 27210535]
- J Autoimmun. 2020 May;109:102421. [PMID: 32019685]
- Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):32-38. [PMID: 29742056]